Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are ...

A once-daily oral GLP-1 conferred greater reductions in HbA1c and body weight than placebo among adults with type 2 diabetes, ...

The injectable prescription medicine is primarily used to treat type 2 diabetes ... exercise, improved diet and optimal sleep, Siegel said. "Having said that, these weight-loss drugs (including ...

Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...

One solution some policymakers may try is restricting the number of people on Medicaid who can use the pricey diabetes drugs for weight-loss purposes ... try diet and exercise programs or less ...

Obesity can cause hypertension, Type 2 diabetes and ... want to use GLP-1s for weight loss to meet a certain number on the body-mass index or try diet and exercise programs or less expensive ...